Pre-order Enquiry
Request Free Sample
Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size, Status and Forecast 2021-2027
SKU ID : QYR-17250552 | Publishing Date : 22-Jan-2021 | No. of pages : 96
Detailed TOC of Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Short-Acting Bronchodilators
1.2.3 Corticosteroids
1.2.4 Methylxanthines
1.2.5 Long-Acting Bronchodilators
1.2.6 Phosphodiesterase-4 Inhibitors
1.2.7 Others
1.3 Market by Application
1.3.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Perspective (2016-2027)
2.2 Chronic Obstructive Pulmonary Disorder (COPD) Growth Trends by Regions
2.2.1 Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chronic Obstructive Pulmonary Disorder (COPD) Historic Market Share by Regions (2016-2021)
2.2.3 Chronic Obstructive Pulmonary Disorder (COPD) Forecasted Market Size by Regions (2022-2027)
2.3 Chronic Obstructive Pulmonary Disorder (COPD) Industry Dynamic
2.3.1 Chronic Obstructive Pulmonary Disorder (COPD) Market Trends
2.3.2 Chronic Obstructive Pulmonary Disorder (COPD) Market Drivers
2.3.3 Chronic Obstructive Pulmonary Disorder (COPD) Market Challenges
2.3.4 Chronic Obstructive Pulmonary Disorder (COPD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Obstructive Pulmonary Disorder (COPD) Players by Revenue
3.1.1 Global Top Chronic Obstructive Pulmonary Disorder (COPD) Players by Revenue (2016-2021)
3.1.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share by Players (2016-2021)
3.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chronic Obstructive Pulmonary Disorder (COPD) Revenue
3.4 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Concentration Ratio
3.4.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Obstructive Pulmonary Disorder (COPD) Revenue in 2020
3.5 Chronic Obstructive Pulmonary Disorder (COPD) Key Players Head office and Area Served
3.6 Key Players Chronic Obstructive Pulmonary Disorder (COPD) Product Solution and Service
3.7 Date of Enter into Chronic Obstructive Pulmonary Disorder (COPD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Obstructive Pulmonary Disorder (COPD) Breakdown Data by Type
4.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Historic Market Size by Type (2016-2021)
4.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Forecasted Market Size by Type (2022-2027)
5 Chronic Obstructive Pulmonary Disorder (COPD) Breakdown Data by Application
5.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Historic Market Size by Application (2016-2021)
5.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size (2016-2027)
6.2 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type
6.2.1 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2021)
6.2.2 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2022-2027)
6.2.3 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2027)
6.3 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application
6.3.1 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2021)
6.3.2 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2022-2027)
6.3.3 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2027)
6.4 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country
6.4.1 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2016-2021)
6.4.2 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size (2016-2027)
7.2 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type
7.2.1 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2021)
7.2.2 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2022-2027)
7.2.3 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2027)
7.3 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application
7.3.1 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2021)
7.3.2 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2022-2027)
7.3.3 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2027)
7.4 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country
7.4.1 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2016-2021)
7.4.2 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size (2016-2027)
8.2 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type
8.2.1 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2027)
8.3 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application
8.3.1 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2027)
8.4 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Region
8.4.1 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size (2016-2027)
9.2 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type
9.2.1 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2021)
9.2.2 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2022-2027)
9.2.3 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2027)
9.3 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application
9.3.1 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2021)
9.3.2 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2022-2027)
9.3.3 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2027)
9.4 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country
9.4.1 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2016-2021)
9.4.2 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size (2016-2027)
10.2 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type
10.2.1 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2027)
10.3 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application
10.3.1 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2027)
10.4 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country
10.4.1 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Chronic Obstructive Pulmonary Disorder (COPD) Introduction
11.1.4 GSK Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021)
11.1.5 GSK Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Chronic Obstructive Pulmonary Disorder (COPD) Introduction
11.2.4 Pfizer Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Chronic Obstructive Pulmonary Disorder (COPD) Introduction
11.3.4 Merck Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021)
11.3.5 Merck Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Chronic Obstructive Pulmonary Disorder (COPD) Introduction
11.4.4 Novartis Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Chronic Obstructive Pulmonary Disorder (COPD) Introduction
11.5.4 AstraZeneca Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021)
11.5.5 AstraZeneca Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Details
11.6.2 Boehringer Ingelheim Business Overview
11.6.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder (COPD) Introduction
11.6.4 Boehringer Ingelheim Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021)
11.6.5 Boehringer Ingelheim Recent Development
11.7 Teva Pharmaceuticals
11.7.1 Teva Pharmaceuticals Company Details
11.7.2 Teva Pharmaceuticals Business Overview
11.7.3 Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Introduction
11.7.4 Teva Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021)
11.7.5 Teva Pharmaceuticals Recent Development
11.8 Ario Pharma
11.8.1 Ario Pharma Company Details
11.8.2 Ario Pharma Business Overview
11.8.3 Ario Pharma Chronic Obstructive Pulmonary Disorder (COPD) Introduction
11.8.4 Ario Pharma Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021)
11.8.5 Ario Pharma Recent Development
11.9 Roche
11.9.1 Roche Company Details
11.9.2 Roche Business Overview
11.9.3 Roche Chronic Obstructive Pulmonary Disorder (COPD) Introduction
11.9.4 Roche Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021)
11.9.5 Roche Recent Development
11.10 Ache
11.10.1 Ache Company Details
11.10.2 Ache Business Overview
11.10.3 Ache Chronic Obstructive Pulmonary Disorder (COPD) Introduction
11.10.4 Ache Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021)
11.10.5 Ache Recent Development
11.11 Almirall
11.11.1 Almirall Company Details
11.11.2 Almirall Business Overview
11.11.3 Almirall Chronic Obstructive Pulmonary Disorder (COPD) Introduction
11.11.4 Almirall Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021)
11.11.5 Almirall Recent Development
11.12 Aquinox Pharmaceuticals
11.12.1 Aquinox Pharmaceuticals Company Details
11.12.2 Aquinox Pharmaceuticals Business Overview
11.12.3 Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Introduction
11.12.4 Aquinox Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021)
11.12.5 Aquinox Pharmaceuticals Recent Development
11.13 Asmacure
11.13.1 Asmacure Company Details
11.13.2 Asmacure Business Overview
11.13.3 Asmacure Chronic Obstructive Pulmonary Disorder (COPD) Introduction
11.13.4 Asmacure Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021)
11.13.5 Asmacure Recent Development
11.14 Astellas Pharma
11.14.1 Astellas Pharma Company Details
11.14.2 Astellas Pharma Business Overview
11.14.3 Astellas Pharma Chronic Obstructive Pulmonary Disorder (COPD) Introduction
11.14.4 Astellas Pharma Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021)
11.14.5 Astellas Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Short-Acting Bronchodilators
Table 3. Key Players of Corticosteroids
Table 4. Key Players of Methylxanthines
Table 5. Key Players of Long-Acting Bronchodilators
Table 6. Key Players of Phosphodiesterase-4 Inhibitors
Table 7. Key Players of Others
Table 8. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Regions (2016-2021)
Table 12. Global Chronic Obstructive Pulmonary Disorder (COPD) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Regions (2022-2027)
Table 14. Chronic Obstructive Pulmonary Disorder (COPD) Market Trends
Table 15. Chronic Obstructive Pulmonary Disorder (COPD) Market Drivers
Table 16. Chronic Obstructive Pulmonary Disorder (COPD) Market Challenges
Table 17. Chronic Obstructive Pulmonary Disorder (COPD) Market Restraints
Table 18. Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Players (2016-2021)
Table 20. Global Top Chronic Obstructive Pulmonary Disorder (COPD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Obstructive Pulmonary Disorder (COPD) as of 2020)
Table 21. Ranking of Global Top Chronic Obstructive Pulmonary Disorder (COPD) Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Chronic Obstructive Pulmonary Disorder (COPD) Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Chronic Obstructive Pulmonary Disorder (COPD) Product Solution and Service
Table 25. Date of Enter into Chronic Obstructive Pulmonary Disorder (COPD) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share by Type (2016-2021)
Table 29. Global Chronic Obstructive Pulmonary Disorder (COPD) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share by Application (2016-2021)
Table 33. Global Chronic Obstructive Pulmonary Disorder (COPD) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2022-2027) & (US$ Million)
Table 65. GSK Company Details
Table 66. GSK Business Overview
Table 67. GSK Chronic Obstructive Pulmonary Disorder (COPD) Product
Table 68. GSK Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) & (US$ Million)
Table 69. GSK Recent Development
Table 70. Pfizer Company Details
Table 71. Pfizer Business Overview
Table 72. Pfizer Chronic Obstructive Pulmonary Disorder (COPD) Product
Table 73. Pfizer Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) & (US$ Million)
Table 74. Pfizer Recent Development
Table 75. Merck Company Details
Table 76. Merck Business Overview
Table 77. Merck Chronic Obstructive Pulmonary Disorder (COPD) Product
Table 78. Merck Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) & (US$ Million)
Table 79. Merck Recent Development
Table 80. Novartis Company Details
Table 81. Novartis Business Overview
Table 82. Novartis Chronic Obstructive Pulmonary Disorder (COPD) Product
Table 83. Novartis Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) & (US$ Million)
Table 84. Novartis Recent Development
Table 85. AstraZeneca Company Details
Table 86. AstraZeneca Business Overview
Table 87. AstraZeneca Chronic Obstructive Pulmonary Disorder (COPD) Product
Table 88. AstraZeneca Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) & (US$ Million)
Table 89. AstraZeneca Recent Development
Table 90. Boehringer Ingelheim Company Details
Table 91. Boehringer Ingelheim Business Overview
Table 92. Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder (COPD) Product
Table 93. Boehringer Ingelheim Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) & (US$ Million)
Table 94. Boehringer Ingelheim Recent Development
Table 95. Teva Pharmaceuticals Company Details
Table 96. Teva Pharmaceuticals Business Overview
Table 97. Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Product
Table 98. Teva Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) & (US$ Million)
Table 99. Teva Pharmaceuticals Recent Development
Table 100. Ario Pharma Company Details
Table 101. Ario Pharma Business Overview
Table 102. Ario Pharma Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) & (US$ Million)
Table 103. Ario Pharma Recent Development
Table 104. Roche Company Details
Table 105. Roche Business Overview
Table 106. Roche Chronic Obstructive Pulmonary Disorder (COPD) Product
Table 107. Roche Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) & (US$ Million)
Table 108. Roche Recent Development
Table 109. Ache Company Details
Table 110. Ache Business Overview
Table 111. Ache Chronic Obstructive Pulmonary Disorder (COPD) Product
Table 112. Ache Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) & (US$ Million)
Table 113. Ache Recent Development
Table 114. Almirall Company Details
Table 115. Almirall Business Overview
Table 116. Almirall Chronic Obstructive Pulmonary Disorder (COPD) Product
Table 117. Almirall Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) & (US$ Million)
Table 118. Almirall Recent Development
Table 119. Aquinox Pharmaceuticals Company Details
Table 120. Aquinox Pharmaceuticals Business Overview
Table 121. Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Product
Table 122. Aquinox Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) & (US$ Million)
Table 123. Aquinox Pharmaceuticals Recent Development
Table 124. Asmacure Company Details
Table 125. Asmacure Business Overview
Table 126. Asmacure Chronic Obstructive Pulmonary Disorder (COPD) Product
Table 127. Asmacure Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) & (US$ Million)
Table 128. Asmacure Recent Development
Table 129. Astellas Pharma Company Details
Table 130. Astellas Pharma Business Overview
Table 131. Astellas Pharma Chronic Obstructive Pulmonary Disorder (COPD) Product
Table 132. Astellas Pharma Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) & (US$ Million)
Table 133. Astellas Pharma Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Type: 2020 VS 2027
Figure 2. Short-Acting Bronchodilators Features
Figure 3. Corticosteroids Features
Figure 4. Methylxanthines Features
Figure 5. Long-Acting Bronchodilators Features
Figure 6. Phosphodiesterase-4 Inhibitors Features
Figure 7. Others Features
Figure 8. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Application: 2020 VS 2027
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Chronic Obstructive Pulmonary Disorder (COPD) Report Years Considered
Figure 12. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Regions: 2020 VS 2027
Figure 15. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Regions (2022-2027)
Figure 16. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Players in 2020
Figure 17. Global Top Chronic Obstructive Pulmonary Disorder (COPD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Obstructive Pulmonary Disorder (COPD) as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Chronic Obstructive Pulmonary Disorder (COPD) Revenue in 2020
Figure 19. Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share by Type (2016-2021)
Figure 20. Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share by Type (2022-2027)
Figure 21. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Type (2016-2027)
Figure 23. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Application (2016-2027)
Figure 24. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Country (2016-2027)
Figure 25. United States Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Type (2016-2027)
Figure 29. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Application (2016-2027)
Figure 30. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Country (2016-2027)
Figure 31. Germany Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Region (2016-2027)
Figure 41. China Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Type (2016-2027)
Figure 49. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Application (2016-2027)
Figure 50. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Country (2016-2027)
Figure 51. Mexico Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Country (2016-2027)
Figure 57. Turkey Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. GSK Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021)
Figure 64. AstraZeneca Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021)
Figure 65. Boehringer Ingelheim Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021)
Figure 66. Teva Pharmaceuticals Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021)
Figure 67. Ario Pharma Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021)
Figure 68. Roche Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021)
Figure 69. Ache Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021)
Figure 70. Almirall Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021)
Figure 71. Aquinox Pharmaceuticals Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021)
Figure 72. Asmacure Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021)
Figure 73. Astellas Pharma Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
Keyplayers in Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size, Status and Forecast 2021-2027
GSKPfizer
Merck
Novartis
AstraZeneca
Boehringer Ingelheim
Teva Pharmaceuticals
Ario Pharma
Roche
Ache
Almirall
Aquinox Pharmaceuticals
Asmacure
Astellas Pharma
Request Sample
Request Discount
